|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/095 |
| (11) | Number of the document | 2976101 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14711232.0 |
| Date of filing the European patent application | 2014-03-17 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/055355 |
| Date | 2014-03-17 |
| (87) | Number | WO 2014/147044 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361802918 P | 2013-03-18 | US | |
| 201361874008 P | 2013-09-05 | US |
| (72) |
BAINE, Yaela, US
MILLER, Jacqueline, US
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | METHOD OF TREATMENT |
| METHOD OF TREATMENT |